NCT00314938View on ClinicalTrials.gov

A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone Deficiency

PHASE2TerminatedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Growth Hormone Deficiency
Interventions
DRUG

PHA-794428

Trial Locations (7)

1050

Pfizer Investigational Site, Brussels

1090

Pfizer Investigational Site, Brussels

2650

Pfizer Investigational Site, Edegem

49202

Pfizer Investigational Site, Petah Tikva

75019

Pfizer Investigational Site, Paris

91054

Pfizer Investigational Site, Erlangen

CF14 4XN

Pfizer Investigational Site, Cardiff

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY